Automation and Technology
DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — Analytics company QuintilesIMS has a new name. Effective Nov. 6, the company will do business as IQVIA, with its name ticker symbol on the New York Stock Exchange set to switch to IQV on Nov. 15. The name change comes almost a year and a half after Quintiles merged with IMS Health in a $9 billion deal.
SILVER SPRING, Md. — The Food and Drug Administration has approved a new lymphoma treatment from AstraZeneca. The company announced this week that its Calquence (acalabrutinib) had been approved to treat patients with mantle cell lymphoma in patients who have received at least one prior therapy.
FARMVILLE, N.C. — Following its August approval, CMP Pharma on Monday launched its CaroSpir, a spironolactone oral suspension. Company leadership said CaroSpir is the first approved oral liquid dosage form of the diuretic.
The formulation is aimed at meeting the needs of patients with difficulty swallowing. Up to this point, CMP Pharma said these patients have relied on compounded formulations with limited shelf life and potential unreimbursed costs.